NCT05276167View on ClinicalTrials.gov

Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
High-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaPerfusion; ComplicationsIntraoperative Complications
Interventions
DEVICE

hyperthermic intravesical perfusion

Participants in the experimental group will be treated with hyperthermic intravesical perfusion before receiving radical cystectomy

Trial Locations (1)

450008

RECRUITING

BR-PRG, Zhengzhou

All Listed Sponsors
lead

Henan Cancer Hospital

OTHER_GOV